The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospital
Open accessAbstract
Acetaminophen overdose is a common reason for hospital admission and the most frequent cause of hepatotoxicity in the Western world. Early identification would facilitate patient-individualized treatment strategies. We investigated the potential of a panel of novel biomarkers (with enhanced liver expression or linked to the mechanisms of toxicity) to identify patients with acetaminophen-induced acute liver injury (ALI) at first presentation to the hospital when currently used markers are within the normal range. In the first hospital presentation plasma sample from patients (n = 129), we measured microRNA-122 (miR-122; high liver specificity), high mobility group box-1 (HMGB1; marker of necrosis), full-length and caspase-cleaved keratin-18 (K18; markers of necrosis and apoptosis), and glutamate dehydrogenase (GLDH; marker of mitochondrial dysfunction). Receiver operator characteristic curve analysis and positive/negative predictive values were used to compare sensitivity to report liver injury versus alanine transaminase (ALT) and International Normalized Ratio (INR). In all patients, biomarkers at first presentation significantly correlated with peak ALT or INR. In patients presenting with normal ALT or INR, miR-122, HMGB1, and necrosis K18 identified the development of liver injury (n = 15) or not (n = 84) with a high degree of accuracy and significantly outperformed ALT, INR, and plasma acetaminophen concentration for the prediction of subsequent ALI (n = 11) compared with no ALI (n = 52) in patients presenting within 8 hours of overdose. Conclusion : Elevations in plasma miR-122, HMGB1, and necrosis K18 identified subsequent ALI development in patients on admission to the hospital, soon after acetaminophen overdose, and in patients with ALTs in the normal range. The application of such a biomarker panel could improve the speed of clinical decision-making, both in the treatment of ALI and the design/execution of patient-individualized treatment strategies. (Hepatology 2013;58:777–787)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, glutamate dehydrogenase and micro‐RNA‐122 show promise as being more sensitive and specific biomarkers for liver injury compared with ALT from clinical studies in patients with APAP overdose (Table 12).210,211”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [211]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Antoine, D. J., Jenkins, R. E., Dear, J. W., Williams, D. P., McGill, M. R., Sharpe, M. R., Craig, D. G., Simpson, K. J., Jaeschke, H., & Park, B. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.019 · Cited by 309
Self-citationRetractedMechanistic biomarkers in acute liver injury: Are we there yet?
Adebayo, D., Mookerjee, R. P., & Jalan, R. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.017 · Cited by 21
RetractedMonocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,249
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Jaeschke, H., McGill, M. R., & Ramachandran, A. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.602688 · Cited by 964
Characterization of microRNA expression profiles in normal human tissues.
Liang, Y., Ridzon, D., Wong, L., & Chen, C. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-166 · Cited by 881
McGill, M. R., Sharpe, M. R., Williams, C. D., Taha, M., Curry, S. C., & Jaeschke, H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59755 · Cited by 763
Circulating microRNAs as potential markers of human drug-induced liver injury
Starkey Lewis, P. J., Dear, J., Platt, V., Simpson, K. J., Craig, D. G. N., Antoine, D. J., French, N. S., Dhaun, N., Webb, D. J., Costello, E. M., et al. (2011) · Hepatology · doi:10.1002/hep.24538 · Cited by 515
Self-citationAntoine, D. J., Williams, D. P., Kipar, A., Jenkins, R. E., Regan, S. L., Sathish, J. G., Kitteringham, N. R., & Park, B. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp235 · Cited by 223
Self-citationAdverse reactions to acetylcysteine and effects of overdose.
Mant, T. G., Tempowski, J. H., Volans, G. N., & Talbot, J. C. (1984) · BMJ · doi:10.1136/bmj.289.6439.217 · Cited by 194
Craig, D. G. N., Bates, C. M., Davidson, J. S., Martin, K. G., Hayes, P. C., & Simpson, K. J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04067.x · Cited by 168
Kerr, F., Dawson, A., Whyte, I. M., Buckley, N., Murray, L., Graudins, A., Chan, B., & Trudinger, B. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.08.040 · Cited by 166
McPhail, M. J. W., Wendon, J. A., & Bernal, W. E. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.023 · Cited by 158
Harrill, A. H., Roach, J., Fier, I., Eaddy, J. S., Kurtz, C. L., Antoine, D. J., Spencer, D. M., Kishimoto, T. K., Pisetsky, D. S., Park, B. K., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.40 · Cited by 119
Self-citationPrescott, K., Stratton, R., Freyer, A. M., Hall, I. P., & Jeune, I. L. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03458.x · Cited by 116
Waring, W. S., Stephen, A. F., Robinson, O. D. G., Dow, M., & Pettie, J. M. (2008) · Clinical Toxicology · doi:10.1080/15563650701864760 · Cited by 90
Serum Apoptosis Markers in Acute Liver Failure: A Pilot Study
Rutherford, A., Hynan, L. S., Borges, C. B. D. S., Forcione, D. G., Blackard, J. T., Lin, W., Gorman, A., Shaikh, O. S., Reuben, A., Harrison, E. M., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.08.007 · Cited by 71
Cummings, J., Hodgkinson, C. L., Odedra, R., Sini, P., Heaton, S. P., Mundt, K., Ward, T. H., Wilkinson, R. W., Growcott, J., Hughes, A. M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2136 · Cited by 65
Mechanism-based bioanalysis and biomarkers for hepatic chemical stress
Antoine, D. J., Mercer, A. E., Williams, D. P., & Park, B. K. (2009) · Xenobiotica · doi:10.1080/00498250903046993 · Cited by 49
Self-citationBechmann, L. P., Marquitan, G., Jochum, C., Saner, F. H., Gerken, G., & Canbay, A. E. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01566.x · Cited by 47
Cited by
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.018 · Cited by 759
The past and present of serum aminotransferases and the future of liver injury biomarkers
McGill, M. R. (2016) · EXCLI journal · doi:10.17179/excli2016-800 · Cited by 487
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Kullak-Ublick, G. A., Andrade, R. J., Merz, M., End, P., Benesic, A., Gerbes, A. L., & Aithal, G. P. (2017) · Gut · doi:10.1136/gutjnl-2016-313369 · Cited by 438
MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
Yang, H., Wang, H., Ju, Z., Ragab, A. A., Lundbäck, P., Long, W., Valdes-Ferrer, S. I., He, M., Pribis, J. P., Li, J., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141318 · Cited by 375
Self-citation
Metadata
- Authors
- Antoine, D. J., Dear, J. W., Lewis, P. S., Platt, V., Coyle, J., Masson, M., Thanacoody, R. H., Gray, A. J., Webb, D. J., Moggs, J. G., Bateman, N. D., Goldring, C. E., & Park, K. B.
- Venue
- Hepatology
- Published
- 2013-08
- Volume
- 58
- Issue
- 2
- Pages
- 777-787
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2093982770
- Cited by
- 427
- References
- 21
- FWCI
- 51.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.